BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1549 related articles for article (PubMed ID: 32988401)

  • 41. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
    Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
    Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.
    Espinet E; Gu Z; Imbusch CD; Giese NA; Büscher M; Safavi M; Weisenburger S; Klein C; Vogel V; Falcone M; Insua-Rodríguez J; Reitberger M; Thiel V; Kossi SO; Muckenhuber A; Sarai K; Lee AYL; Backx E; Zarei S; Gaida MM; Rodríguez-Paredes M; Donato E; Yen HY; Eils R; Schlesner M; Pfarr N; Hackert T; Plass C; Brors B; Steiger K; Weichenhan D; Arda HE; Rooman I; Kopp JL; Strobel O; Weichert W; Sprick MR; Trumpp A
    Cancer Discov; 2021 Mar; 11(3):638-659. PubMed ID: 33060108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.
    Drifka CR; Loeffler AG; Mathewson K; Keikhosravi A; Eickhoff JC; Liu Y; Weber SM; Kao WJ; Eliceiri KW
    Oncotarget; 2016 Nov; 7(46):76197-76213. PubMed ID: 27776346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.
    de Santiago I; Yau C; Heij L; Middleton MR; Markowetz F; Grabsch HI; Dustin ML; Sivakumar S
    Int J Cancer; 2019 Aug; 145(4):1125-1137. PubMed ID: 30720864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells' heterogeneity.
    Schlesinger Y; Yosefov-Levi O; Kolodkin-Gal D; Granit RZ; Peters L; Kalifa R; Xia L; Nasereddin A; Shiff I; Amran O; Nevo Y; Elgavish S; Atlan K; Zamir G; Parnas O
    Nat Commun; 2020 Sep; 11(1):4516. PubMed ID: 32908137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.
    Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H
    Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.
    Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C
    Front Immunol; 2021; 12():790661. PubMed ID: 34925373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
    Moffitt RA; Marayati R; Flate EL; Volmar KE; Loeza SG; Hoadley KA; Rashid NU; Williams LA; Eaton SC; Chung AH; Smyla JK; Anderson JM; Kim HJ; Bentrem DJ; Talamonti MS; Iacobuzio-Donahue CA; Hollingsworth MA; Yeh JJ
    Nat Genet; 2015 Oct; 47(10):1168-78. PubMed ID: 26343385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metastasis of pancreatic tumors].
    Häberle L; Braren R; Schlitter AM; Esposito I
    Pathologe; 2015 Nov; 36 Suppl 2():176-80. PubMed ID: 26391249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-cell RNA sequencing highlights epithelial and microenvironmental heterogeneity in malignant progression of pancreatic ductal adenocarcinoma.
    Li J; Wei T; Ma K; Zhang J; Lu J; Zhao J; Huang J; Zeng T; Xie Y; Liang Y; Li X; Zhang Q; Liang T
    Cancer Lett; 2024 Mar; 584():216607. PubMed ID: 38246225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.
    Tjomsland V; Spångeus A; Välilä J; Sandström P; Borch K; Druid H; Falkmer S; Falkmer U; Messmer D; Larsson M
    Neoplasia; 2011 Aug; 13(8):664-75. PubMed ID: 21847358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma.
    Croft W; Pearce H; Margielewska-Davies S; Lim L; Nicol SM; Zayou F; Blakeway D; Marcon F; Powell-Brett S; Mahon B; Merard R; Zuo J; Middleton G; Roberts K; Brown RM; Moss P
    Elife; 2023 Jun; 12():. PubMed ID: 37350578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.
    Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M
    Front Immunol; 2021; 12():730746. PubMed ID: 34630409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.
    Kadera BE; Li L; Toste PA; Wu N; Adams C; Dawson DW; Donahue TR
    PLoS One; 2013; 8(8):e71978. PubMed ID: 23991015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.